Document is current
Any future updates will be listed below
-
Authors
Davis, Mellar https://orcid.org/0000-0002-7903-3993
Loprinzi, Charles
- License Information
-
More Information
Article History
Received: 20 January 2022
Accepted: 2 August 2022
First Online: 11 August 2022
Declarations
:
: NA
: NA
: NA
: Mellar Davis: no competing interest; Charles Loprinzi: PledPharma, Disarm Therapeutics, Mitsubishi Tanabe Asahi Kasei, Metys Pharmaceuticals, OnQuality, NKMax, Novartis, HengRui, Nuro Bio, Osmol Therapeutics, Inc., Grunentha.
